Evidence review

VIP for Postherpetic Neuralgia: Evidence Review

#peptide#matrix
bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects (paste without context)

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `vip-postherpetic`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/vip-postherpetic

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/vip-postherpetic/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Paste-ready package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/vip-postherpetic/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/vip-postherpetic/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/vip-postherpetic/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

Why VIP might help you

  1. Therefore for you: If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.

How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

  • VIP → immune / autonomic

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 4
  • Claims tagged human evidence: 3
  • Claims tagged preclinical (animal/lab): 2
  • Claims tagged anecdotal: 0
  • Reddit posts catalogued: 0
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 4

Logic: No social posts catalogued yet — we cannot report what people are saying on Reddit or X from this ledger.

Quantified confidence (this ledger): 0.54 / 1.00 — low–moderate — mostly preclinical

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Studies of vasoactive intestinal polypeptide expression in injured peripheral nerves (source s9)

1990 human nerve injury study on VIP expression.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Vasoactive Intestinal Peptide and Nerve Regeneration (source s10)

1991 animal nerve injury model.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

Vasoactive Intestinal Peptide (VIP) Prevents Experimental Arthritis (source s11)

Summary of mouse arthritis study.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

Herpes Zoster (Shingles) and Postherpetic Neuralgia (source s0)

Clinical review of PHN pathology.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Postherpetic neuralgia · condition map

Evidence map

Hover a node — its path lights up. Click to open the article.

Full map →
Evidence · 4 sources · swipe →chain c473b42b7e8a · verify chain · provenance
Evidence ledger 5 · tier-ranked · API
human
No human clinical trials test VIP for postherpetic neuralgia.
human
Postherpetic neuralgia stems from nerve damage and inflammation after shingles.
sources: s0
preclinical
VIP prevents experimentally induced arthritis in mice via anti-inflammatory actions.
sources: s11
humanlow confidence
VIP expression increases in injured human sural nerves after injury.
sources: s9
preclinicallow confidence
VIP concentrations rise in injured rabbit nerves, greater without repair.
sources: s10
Model swipes · 1 from 1 model · swipe →verify
1 / 1
grok/grok-4.3writer
redraft2026-06-29 22:22
VIP for Postherpetic Neuralgia: Evidence Review · 5 claims · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: Vip for Postherpetic
Slug: vip-postherpetic
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_focus","condition":null,"condition_key":null,"primary_peptide":null,"peptides_in_scope":[{"id":"vip","name":"VIP"}],"drugs_in_scope":[],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"section_title":"What's breaking down","degenerative_why":[],"degenerative_layers"
it output
{
  "slug": "vip-postherpetic",
  "title": "VIP for Postherpetic Neuralgia: Evidence Review",
  "body": "## What's breaking down\n\nPostherpetic neuralgia follows shingles, an outbreak of the varicella-zoster virus. The virus reactivates in sensory ganglia, travels along nerves, and causes inflammation plus direct neuronal damage. Pain persists after the rash clears because damaged nerve fibers send scrambled or amplified signals. Layers include peripheral nerve fiber loss, central sensitization in the spinal cord, ongoing low-grade inflammation, and possible autonomic fiber disruption that affects local blood flow and sweating.\n\nIf nerve repair lags behind ongoing irritation, symptoms continue. VIP research focuses on immune balance and autonomic signaling rather than direct pain masking.\n\n## Why VIP might help you\n\nVIP is discussed for the immune and autonomic layer. If your postherpetic pain involves persistent inflammation around damaged nerves or altered autonomic control of blood flow, the following logic applies.\n\n1. Damaged nerves after shingles show changes in neuropeptide expression, including VIP.\n2. VIP acts on receptors that dampen pro-inflammatory cytokines in preclinical models.\n3. Therefore for you: If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\n\nAnimal work shows VIP rises in i
0fd83afc26cd2980
Ask this article · 7 suggested prompts

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (human tier): "No human clinical trials test VIP for postherpetic neuralgia."?
ask vip-postherpetic claim c1 · paste includes §SELF
What does the ledger say about this (human tier): "Postherpetic neuralgia stems from nerve damage and inflammation after shingles."?
ask vip-postherpetic claim c5 · paste includes §SELF
What does the ledger say about this (preclinical tier): "VIP prevents experimentally induced arthritis in mice via anti-inflammatory actions."?
ask vip-postherpetic claim c3 · paste includes §SELF
What does the ledger say about this (human tier): "VIP expression increases in injured human sural nerves after injury."?
ask vip-postherpetic claim c2 · paste includes §SELF
What does the ledger say about this (preclinical tier): "VIP concentrations rise in injured rabbit nerves, greater without repair."?
ask vip-postherpetic claim c4 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about VIP for Postherpetic Neuralgia: Evidence Review — and what would you need me to tell you first?
ask vip-postherpetic condition gaps · paste includes §SELF
What good and bad outcomes are documented for VIP for Postherpetic Neuralgia: Evidence Review (studies vs anecdotes)?
ask vip-postherpetic good bad experiences · paste includes §SELF
vip-postherpetic · posted 2026-06-29 · updated 2026-06-29 · 1 prior revision · grok/grok-4.3
Ledger API & provenance
Provenance · 1 model pass · 25600 tokens · $0 · 1 model
chain head 1fb074b86a59245b
write grok/grok-4.3 · 2026-06-29 22:22 · 25600 tok · 1fb074b86a59
verify chain →
Live ledger · 6 payloads · 1 turn
recent activity · inspect
webhook_in blooio · 2026-06-29 22:22
PROTOCOL_RUN dispatch · 2026-06-29 22:22 · t_1vz6e1px
PROTOCOL_RUN dispatch · 2026-06-29 22:22 · t_1vz6e1px
webhook_in blooio · 2026-06-29 22:22
webhook_in blooio · 2026-06-29 22:22
webhook_in blooio · 2026-06-29 22:22
view full ledger & cards →
REST + ledger
read GET /api/articles/vip-postherpetic · GET /api/articles/vip-postherpetic?format=post (the editable body)
create/replace POST /api/articles/vip-postherpetic · PUT /api/articles/vip-postherpetic (replace, keeps revision) · PATCH /api/articles/vip-postherpetic (merge)
delete DELETE /api/articles/vip-postherpetic
writes need header x-terminal-key
LLM bundle GET /api/articles/vip-postherpetic/bundle?format=markdown — body + claims + sources + provenance + manifest
post claim POST /api/protocol/claim · iMessage claim vip-postherpetic|tier|assertion
system map GET /api/articles/system-map?format=markdown — root index; every widget self-explains via §SELF / _self
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →